Genetic ablation of fibroblast activation protein alpha attenuates left ventricular dilation after myocardial infarction

PLoS One. 2021 Mar 5;16(3):e0248196. doi: 10.1371/journal.pone.0248196. eCollection 2021.

Abstract

Introduction: Regulating excessive activation of fibroblasts may be a promising target to optimize extracellular matrix deposition and myocardial stiffness. Fibroblast activation protein alpha (FAP) is upregulated in activated fibroblasts after myocardial infarction (MI), and alters fibroblast migration in vitro. We hypothesized that FAP depletion may have a protective effect on left ventricular (LV) remodeling after MI.

Materials and methods: We used the model of chronic MI in homozygous FAP deficient mice (FAP-KO, n = 51) and wild type mice (WT, n = 55) to analyze wound healing by monocyte and myofibroblast infiltration. Heart function and remodeling was studied by echocardiography, morphometric analyses including capillary density and myocyte size, collagen content and in vivo cell-proliferation. In non-operated healthy mice up to 6 months of age, morphometric analyses and collagen content was assessed (WT n = 10, FAP-KO n = 19).

Results: Healthy FAP-deficient mice did not show changes in LV structure or differences in collagen content or cardiac morphology. Infarct size, survival and cardiac function were not different between FAP-KO and wildtype mice. FAP-KO animals showed less LV-dilation and a thicker scar, accompanied by a trend towards lower collagen content. Wound healing, assessed by infiltration with inflammatory cells and myofibroblasts were not different between groups.

Conclusion: We show that genetic ablation of FAP does not impair cardiac wound healing, and attenuates LV dilation after MI in mice. FAP seems dispensable for normal cardiac function and homeostasis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Dilatation, Pathologic
  • Endopeptidases / deficiency*
  • Endopeptidases / metabolism
  • Female
  • Heart Ventricles / metabolism*
  • Heart Ventricles / pathology
  • Membrane Proteins / deficiency*
  • Membrane Proteins / metabolism
  • Mice
  • Mice, Knockout
  • Monocytes / metabolism*
  • Monocytes / pathology
  • Myocardial Infarction / genetics
  • Myocardial Infarction / metabolism*
  • Myocardial Infarction / pathology
  • Myocardium / metabolism*
  • Myocardium / pathology
  • Myofibroblasts / metabolism*
  • Myofibroblasts / pathology

Substances

  • Membrane Proteins
  • Endopeptidases
  • fibroblast activation protein alpha

Grants and funding

This work was initially supported by grants from the Interdisciplinary Clinical Research Center Würzburg (to JT, JB: IZKF E-140). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.